Company profile
Halo Collective Inc.
OTC: HCANF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#527 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 48
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, workforce scale · ↓ return on equity, market scale
Methodology →Revenue TTM
$18.0M
Rev growth YoY (TTM)
-43.0%
Net income (FY)
-$83.9M
Employees
114
as of 2026-08-29
Market cap
$15.1k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$24.5M$24.5M2022
Net income-$83.9M-$83.9M2022
Operating income-$34.9M-$34.9M2022
Total assets$56.9M$56.9M2022
Liabilities$27.5M$27.5M2022
Equity$32.6M$32.6M2022
Revenue trend
FY2015 – FY2022 · USD
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Halo Collective Inc.’s revenue?
Halo Collective Inc. booked $24.5M in FY2022 revenue, contracting 32% year over year — slower than 76% of Healthcare companies we track, at a -341.8% net margin.
Peers · Healthcare
Entrada Therapeutics, Inc.46DMetagenomi, Inc. Common Stock40DIonic Brands Corp.——Precipio, Inc.69BAlumis Inc.35DCovalon Technologies Ltd.78B+Key facts
CEOMarshall Minor
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: HCANF
Employees114
IPO date2010-09-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.